First report of IMI-1-producing colistin-resistant Enterobacter clinical isolate in Ireland, March 2013.

Hdl Handle:
http://hdl.handle.net/10147/302269
Title:
First report of IMI-1-producing colistin-resistant Enterobacter clinical isolate in Ireland, March 2013.
Authors:
Boo, Tw; O Connell, N; Power, L; O Connor, M; King, J; McGrath, E; Hill, R; Hopkins, Kl; Woodford, N
Affiliation:
Department of Medical Microbiology, Galway University Hospitals, HSE West, Ireland.
Citation:
First report of IMI-1-producing colistin-resistant Enterobacter clinical isolate in Ireland, March 2013. 2013, 18 (31): Euro Surveill.
Publisher:
Euro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletin
Journal:
Euro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletin
Issue Date:
Aug-2013
URI:
http://hdl.handle.net/10147/302269
PubMed ID:
23929227
Abstract:
We report the first case in Ireland of an IMI-1 carbapenemase- producing Enterobacter asburiae, which was resistant to both colistin and fosfomycin. The circumstances under which this isolate was acquired were unclear. Several reports of IMI-producing Enterobacter spp. have emerged in recent years, and colistin resistance in Enterobacteriaceae is also increasingly reported. Laboratories should be aware of the unusual antibiograms of IMI-producing isolates.
Item Type:
Article
Language:
en
ISSN:
1560-7917

Full metadata record

DC FieldValue Language
dc.contributor.authorBoo, Twen_GB
dc.contributor.authorO Connell, Nen_GB
dc.contributor.authorPower, Len_GB
dc.contributor.authorO Connor, Men_GB
dc.contributor.authorKing, Jen_GB
dc.contributor.authorMcGrath, Een_GB
dc.contributor.authorHill, Ren_GB
dc.contributor.authorHopkins, Klen_GB
dc.contributor.authorWoodford, Nen_GB
dc.date.accessioned2013-09-25T13:54:09Z-
dc.date.available2013-09-25T13:54:09Z-
dc.date.issued2013-08-
dc.identifier.citationFirst report of IMI-1-producing colistin-resistant Enterobacter clinical isolate in Ireland, March 2013. 2013, 18 (31): Euro Surveill.en_GB
dc.identifier.issn1560-7917-
dc.identifier.pmid23929227-
dc.identifier.urihttp://hdl.handle.net/10147/302269-
dc.description.abstractWe report the first case in Ireland of an IMI-1 carbapenemase- producing Enterobacter asburiae, which was resistant to both colistin and fosfomycin. The circumstances under which this isolate was acquired were unclear. Several reports of IMI-producing Enterobacter spp. have emerged in recent years, and colistin resistance in Enterobacteriaceae is also increasingly reported. Laboratories should be aware of the unusual antibiograms of IMI-producing isolates.en_GB
dc.language.isoenen
dc.publisherEuro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletinen_GB
dc.rightsArchived with thanks to Euro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletinen_GB
dc.titleFirst report of IMI-1-producing colistin-resistant Enterobacter clinical isolate in Ireland, March 2013.en_GB
dc.typeArticleen
dc.contributor.departmentDepartment of Medical Microbiology, Galway University Hospitals, HSE West, Ireland.en_GB
dc.identifier.journalEuro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletinen_GB
dc.description.fundingNo fundingen
dc.description.provinceConnachten
dc.description.peer-reviewpeer-reviewen

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.